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Sir,
In a recently published paper in your journal, Katsuragi et al
(2007) show that peritoneal recurrence in patients with early-stage
gastric cancer relates to the levels of carcinoembryonic antigen
(CEA) and/or cytokeratin 20 (CK 20) transcripts in the peritoneal
lavage specimens from these patients. The authors are convinced
that a positive RT-PCR result identifies the presence
of ‘micrometastatic cells’. In our opinion, there are no grounds
for this presumption. We and others have raised the issue
of the nonspecific expression of so-called tumour markers by
activated lymphoid cells (Kowalewska et al, 2006). CEA
and CK 20 transcripts are markers of limited value for the
detection of cancer cells for several reasons. Both markers
have been shown to be expressed by the haematopoietic cells of
healthy volunteers and of patients with chronic inflammatory
diseases (Jung et al, 1998, 1999; Champelovier et al, 1999, Vlems
et al, 2002). The qRT-PCR-based techniques of CEA and CK 20
detection present the same limitations as conventional RT-PCR,
as researchers were unable to set the cut-off values to distinguish
between cancer and haematopoietic cell expression (Bustin et al,
2004; Schuster et al, 2004). Especially in the experimental
setting studied by Katsuragi et al (2007), one should consider
that CEA expression may be induced in peripheral blood
mononuclear cells by cytokines (Jung et al, 1998; Goeminne
et al, 1999), as increased concentrations of an array of cytokines
characterise peritoneal fluids of cancer patients (Chechlinska et al,
2007). Furthermore, peritoneal lavage samples of cancer-free
patients were found to contain CEA transcripts (Broll et al,
2001). In addition, normal granulocytes that are likely
to be recruited to peritoneal cavity (Hau, 1990) have been shown
to express CK 20 (Jung et al, 1999; Kruger et al, 2001). In fact,
the increased numbers of granulocytes as well as of activated
lymphocytes were demonstrated in the peritoneal fluids
of gastric and colon cancer patients as compared with those
of cancer-free controls (Olszewski et al, 2007).
Unfortunately, none of these limitations, although widely
discussed in numerous papers, have been considered or even
discussed by Katsuragi et al (2007). In effect, the observed
correlation between the positive CEA and CK 20 qRT-PCR
signals and cancer recurrence seems reasonably well documented,
whereas the statement that the authors detect ‘free cancer cells’ in
their study, expressed already in the title and then subsequently
used through the methods section to discussion, is totally
unwarranted.
Considering the above, the measurements of the markers
described by Katsuragi et al (2007) may reflect the presence
of inflammatory cells rather than micrometastatic cells: the
more so because as many as 35% of cytology-negative/PCR-
positive patients developed no peritoneal metastases. Nevertheless,
prognosis for PCR-positive patients was shown to be significantly
worse than for PCR-negative patients, and this was in accordance
with the recent data of Crumley et al (2006) and Deans et al (2007),
who linked inflammation symptoms with adverse prognosis
in patients with gastric cancer. However, there are simpler
and cheaper methods than qRT-PCR to assess inflammatory
parameters.
The study of Katsuragi et al (2007) is also methodologically
flawed. The GAPDH gene was used as an internal control
and a reference gene. The GAPDH gene is known for the presence
of its numerous pseudogenes, which makes it inadequate
as a reference gene in non-DNased total RNA samples, such as
those prepared by Katsuragi et al (2007). In addition, the reader
learns nothing about the standardisation of RNA quantities
subjected to reverse transcription, necessary to make a reliable
comparison of samples containing different cell counts.
Finally, Katsuragi et al (2007) use the inexplicable and
inappropriate term ‘tumour nucleotides’, and for reasons that
are far from obvious the disseminated cancer cells are called
‘isolated’ cells, although no isolation or enrichment procedure was
performed. The authors have not applied the idea of micro-
metastases detection in cancer cell-enriched populations, one of
many detection methods focused to enhance specificity and the
only one which produced an assay that received FDA clearance
(Smerage and Hayes, 2006). Published online 15 January 2008
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